The DOI matches its Crossref record; 276 of the 276 references it cites were found in a registry or an index.
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Open accessAbstract
Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to 50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate from resident tissue-specific macrophages and from newly recruited monocytes. TAMs' variability strongly depends on cancer type, stage, and intratumor heterogeneity. Majority of TAMs are programmed by tumor microenvironment to support primary tumor growth and metastatic spread. However, TAMs can also restrict tumor growth and metastasis. In this review, we summarized the knowledge about the role of TAMs in tumor growth, metastasis and in the response to cancer therapy in patients with five aggressive types of cancer: breast, colorectal, lung, ovarian, and prostate cancers that are frequently metastasize into distant organs resulting in high mortality of the patients. Two major TAM parameters are applied for the evaluation of TAM correlation with the cancer progression: total amount of TAMs and specific phenotype of TAMs identified by functional biomarkers. We summarized the data generated in the wide range of international patient cohorts on the correlation of TAMs with clinical and pathological parameters of tumor progression including lymphatic and hematogenous metastasis, recurrence, survival, therapy efficiency. We described currently available biomarkers for TAMs that can be measured in patients' samples (tumor tissue and blood). CD68 is the major biomarker for the quantification of total TAM amounts, while transmembrane receptors (stabilin-1, CD163, CD206, CD204, MARCO) and secreted chitinase-like proteins (YKL-39, YKL-40) are used as biomarkers for the functional TAM polarization. We also considered that specific role of TAMs in tumor progression can depend on the localization in the intratumoral compartments. We have made the conclusion for the role of TAMs in primary tumor growth, metastasis, and therapy sensitivity for breast, colorectal, lung, ovarian, and prostate cancers. In contrast to other cancer types, majority of clinical studies indicate that TAMs in colorectal cancer have protective role for the patient and interfere with primary tumor growth and metastasis. The accumulated data are essential for using TAMs as biomarkers and therapeutic targets to develop cancer-specific immunotherapy and to design efficient combinations of traditional therapy and new immunomodulatory approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–276 of 276
Klingen, T. A., Chen, Y., Aas, H., Wik, E., & Akslen, L. A. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.09.001 · Cited by 67
Riabov, V., Yin, S., Song, B., Avdic, A., Schledzewski, K., Ovsiy, I., Gratchev, A. N., Verdiell, M. L., Sticht, C., Schmuttermaier, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8857 · Cited by 65
Self-citationPredicting and Overcoming Chemotherapeutic Resistance in Breast Cancer
Chun, K., Park, J. H., & Fan, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6020-5_4 · Cited by 64
Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
Lo, C. H., & Lynch, C. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00247 · Cited by 63
Lu, X., & Meng, T. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.03.002 · Cited by 62
Repolarizing macrophages improves breast cancer therapy
Cassetta, L., & Pollard, J. W. (2017) · Cell Research · doi:10.1038/cr.2017.63 · Cited by 61
Proteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment
Worzfeld, T., Finkernagel, F., Reinartz, S., Konzer, A., Adhikary, T., Nist, A., Stiewe, T., Wagner, U. A. G., Looso, M., Graumann, J., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000400 · Cited by 61
van der Bij, G. J., Bögels, M., Otten, M. A., Oosterling, S. J., Kuppen, P. J. K., Meijer, S., Beelen, R. H. J., & van Egmond, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.023 · Cited by 59
Sunakawa, Y., Stintzing, S., Cao, S., Heinemann, V., Cremolini, C., Falcone, A., Yang, D., Zhang, W., Ning, Y., Stremitzer, S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv474 · Cited by 59
Parayath, N. N., Gandham, S. K., Leslie, F., & Amiji, M. M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.07.002 · Cited by 59
Johansen, J. S., Brasso, K., Iversen, P., Teisner, B., Garnero, P., Price, P. A., & Christensen, I. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2616 · Cited by 58
Cao, J., Liu, J., Xu, R., Zhu, X., Zhao, X., & Qian, B. (2017) · Oncotarget · doi:10.18632/oncotarget.18743 · Cited by 58
The increase of circulating PD-L1-expressing CD68+ macrophage in ovarian cancer
Qu, Q., Huang, Q. M., Shen, Y., Zhu, Y., & Zhang, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4066-y · Cited by 56
Kalina, J. L., Neilson, D. S., Comber, A. P., Rauw, J. M., Alexander, A., Vergidis, J., & Lum, J. J. (2017) · Cancers · doi:10.3390/cancers9020013 · Cited by 56
Adhikary, T., Wortmann, A., Finkernagel, F., Lieber, S., Nist, A., Stiewe, T., Wagner, U. A. G., Müller‐Brüsselbach, S., Reinartz, S., & Müller, R. (2017) · BMC Genomics · doi:10.1186/s12864-017-3630-9 · Cited by 56
Breast cancer metastasis through the lympho-vascular system
Nathanson, D. S., Krag, D. N., Kuerer, H. M., Newman, L. A., Brown, M. K., Kerjaschki, D., Pereira, E. R., & Padera, T. P. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9902-1 · Cited by 55
Gulubova, M. V., Ananiev, J. R., Yovchev, Y., Julianov, A. E., Karashmalakov, A. G., & Vlaykova, T. I. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9520-9 · Cited by 54
Huang, C., Huang, M., Ma, C., Yeh, Y., Tsai, H., Huang, C., Huang, C., & Wang, J. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0790-3 · Cited by 54
Liu, L., Wang, X., Li, X., Wu, X., Tang, M., & Wang, X. (2017) · Oncology Reports · doi:10.3892/or.2017.6148 · Cited by 54
Kzhyshkowska, J. G., Gratchev, A. N., Brundiers, H., Mamidi, S., Krusell, L., & Goerdt, S. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.05.022 · Cited by 52
Self-citationLindahl, C., Simonsson, M., Bergh, A. R. J., Thysell, E., Antti, H., Sund, M., & Wikström, P. (2009) · PubMed · Cited by 50
Jones, J., Sinder, B. P., Paige, D. J., Soki, F. N., Koh, A. J., Thiele, S., Shiozawa, Y., Hofbauer, L. C., Daignault, S. D., Roca, H., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.11.003 · Cited by 50
Shabo, I., Olsson, H., Elkarim, R. A., Sun, X., & Svanvik, J. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0145-7 · Cited by 49
Prognostic Significance of Serum Soluble CD163 Level in Patients with Epithelial Ovarian Cancer
No, J. H., Moon, J. M., Kim, K., & Kim, Y.-B. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000349892 · Cited by 49
Chemotherapy Induces Macrophage ChemoattractantProtein-1 Production in Ovarian Cancer
Geller, M. A., Bui-Nguyen, T. M., Rogers, L. M., & Ramakrishnan, S. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181e5c442 · Cited by 47
Kim, O., Kang, G.-H., Noh, H., Cha, J.-Y., Lee, H.-J., Yoon, J.-H., Mamura, M., Nam, J., Lee, D. H., Kim, Y. A., et al. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0194-7 · Cited by 46
Valls, A. F., Knipper, K., Giannakouri, E., Sarachaga, V., Hinterkopf, S., Wuehrl, M., Shen, Y., Radhakrishnan, P., Klose, J., Ulrich, A. B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2123 · Cited by 46
Denisov, E. V., Литвяков, Н. В., Zavyalova, M. V., Михайлович, П. В., Vtorushin, S. V., Tsyganov, M. M., Gerashchenko, T. S., Garbukov, Е. Y., Slonimskaya, E. M., & Чердынцева, Н. В. (2014) · Scientific Reports · doi:10.1038/srep04709 · Cited by 43
Alveolar Macrophage Polarisation in Lung Cancer
Almatroodi, S. A., McDonald, C. F., & Pouniotis, D. S. (2014) · Lung Cancer International · doi:10.1155/2014/721087 · Cited by 43
Larionova, I., Zavyalova, M. V., Телегина, Н. С., Buldakov, M. A., Riabov, V., Чердынцева, Н. В., & Kzhyshkowska, J. G. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.08.001 · Cited by 41
Self-citationЛитвяков, Н. В., Tsyganov, M. M., Larionova, I., Ibragimova, M. K., Deryusheva, I. V., Вадимовна, К. П., Slonimskaya, E. M., Frolova, I. G., Чойнзонов, Е. Л., Чердынцева, Н. В., et al. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3594-8 · Cited by 41
Self-citationBuldakov, M. A., Zavyalova, M. V., Krakhmal, N. V., Телегина, Н. С., Vtorushin, S. V., Larionova, I., Riabov, V., Yin, S., Song, B., Чердынцева, Н. В., et al. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.09.011 · Cited by 40
Self-citationThe Cohesive Metastasis Phenotype in Human Prostate Cancer
Harryman, W. L., Hinton, J. P., Rubenstein, C. S., Singh, P. P., Nagle, R. B., Parker, S. J., Knudsen, B. S., & Cress, A. E. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.005 · Cited by 40
Vankerckhoven, A., Wouters, R., Mathivet, T., Ceusters, J., Baert, T., Hoylandt, A. V., Gerhardt, H., Vergote, I. B., & Coosemans, A. (2020) · Cells · doi:10.3390/cells9020305 · Cited by 39
Mwafy, S. E., & El-Guindy, D. M. (2020) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-020-0018-8 · Cited by 39
An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma
Ikoma, N., Raghav, K. P. S., & Chang, G. J. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.05.007 · Cited by 38
Morita, Y., Zhang, R., Leslie, M., Adhikari, S., Hasan, N., Chervoneva, I., Rui, H., & Tanaka, T. (2017) · Oncology Letters · doi:10.3892/ol.2017.6466 · Cited by 37
Characterization of macrophage subpopulations in colon cancer using tissue microarrays
Sickert, D., Aust, D. E., Langer, S., Haupt, I., Baretton, G. B., & Dieter, P. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02129.x · Cited by 36
Stromal PD-1+ tumor-associated macrophages predict poor prognosis in lung adenocarcinoma
Chen, L., Cao, M., Xiao, J., Ma, Q., Zhang, H., Cai, R., Miao, J., Wang, W.-Y., Zhang, H., Luo, M., et al. (2020) · Human Pathology · doi:10.1016/j.humpath.2019.12.007 · Cited by 36
Tumor infiltrating macrophages reduce development of peritoneal colorectal carcinoma metastases
van der Bij, G. J., Bögels, M., Oosterling, S. J., Kroon, J., Schuckmann, D. T. M., de Vries, H. E., Meijer, S., Beelen, R. H. J., & van Egmond, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.040 · Cited by 35
Angiogenic potential of YKL-40 in the dynamics of tumor niche
Pouyafar, A., Heydarabad, M. Z., Mahboob, S., Mokhtarzadeh, A., & Rahbarghazi, R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.050 · Cited by 35
Zhang, W., Tian, J., & Hao, Q. (2013) · Tumor Biology · doi:10.1007/s13277-013-1288-8 · Cited by 33
Yuan, S., Dong, Y., Peng, L., Yang, M., Niu, L., Liu, Z., & Xie, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10483 · Cited by 33
Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression
Wettersten, H. I., Weis, S. M., Pathria, P., Schalscha, T. V., Minami, T., Varner, J. A., & Cheresh, D. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1246 · Cited by 33
YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer
Kzhyshkowska, J. G., Larionova, I., & Liu, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02930 · Cited by 32
Self-citationOsteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival
Li, Y., Sun, B., Pei, B., Li, C.-G., Zhang, Z.-F., Yin, Y.-S., & Wang, C.-L. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.11.054 · Cited by 31
Gerashchenko, T. S., Zavyalova, M. V., Denisov, E. V., Krakhmal, N. V., Pautova, D., Литвяков, Н. В., Vtorushin, S. V., Чердынцева, Н. В., & Михайлович, П. В. (2017) · Acta Naturae · doi:10.32607/20758251-2017-9-1-56-67 · Cited by 31
Montfort, A., Barker-Clarke, R. J., Piskorz, A., Supernat, A. M., Moore, L., Al-Khalidi, S., Böhm, S., Pharoah, P. D. P., McDermott, J. R., Balkwill, F. R., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0822-x · Cited by 31
Maeda, R., Ishii, G., Neri, S., Aoyagi, K., Haga, H., Sasaki, H., Nagai, K., & Ochiai, A. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000044 · Cited by 29
Fujii, T., Yajima, R., Hirakata, T., Miyamoto, T. K., Fujisawa, T., Tsutsumi, S., Ynagita, Y., Iijima, M., & Kuwano, H. (2014) · PubMed · Cited by 29
Denisov, E. V., Skryabin, N. A., Gerashchenko, T. S., Таширева, Л. А., Wilhelm, J., Buldakov, M. A., Sleptcov, A. A., Лебедев, И. Н., Vtorushin, S. V., Zavyalova, M. V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18022 · Cited by 29
Lung Macrophages: Multifunctional Regulator Cells for Metastatic Cells
Mukaida, N., Nosaka, T., Nakamoto, Y., & Baba, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010116 · Cited by 29
Katholnig, K., Schütz, B., Fritsch, S. D., Schörghofer, D., Linke, M., Sukhbaatar, N., Matschinger, J. M., Unterleuthner, D., Hirtl, M., Lang, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124164 · Cited by 29
Chen, C., Zhu, Y.-B., Shen, Y., Zhu, Y., Zhang, X., & Huang, J.-A. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31824212c4 · Cited by 27
Ciucci, A., Zannoni, G. F., Buttarelli, M., Martinelli, E., Mascilini, F., Petrillo, M., Ferrandina, G., Scambia, G., & Gallo, D. (2016) · Oncotarget · doi:10.18632/oncotarget.10797 · Cited by 27
CD204-Positive Tumor-associated Macrophages Relate to Malignant Transformation of Colorectal Adenoma
Taniyama, D., Taniyama, K., Kuraoka, K., YAMAMOTO, H., Zaitsu, J., Saito, A., Sakamoto, N., Sentani, K., Oue, N., & Yasui, W. (2019) · Anticancer Research · doi:10.21873/anticanres.13403 · Cited by 27
Dost, F. S., Kırmızı, B. A., Ensarı, A., İçlı, F., & Akbulut, H. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.12.004 · Cited by 26
Budnik, J., Suri, J. S., Bates, J. E., Bylund, K. C., & Milano, M. T. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.03.020 · Cited by 26
Yin, S., Wang, N., Riabov, V., Mossel, D. M., Larionova, I., Schledzewski, K., Trofimova, O., Sevastyanova, T. N., Zajakina, A., Schmuttermaier, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32685 · Cited by 26
Self-citationТаширева, Л. А., Denisov, E. V., Gerashchenko, T. S., Pautova, D., Buldakov, M. A., Zavyalova, M. V., Kzhyshkowska, J. G., Чердынцева, Н. В., & Михайлович, П. В. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.11.012 · Cited by 24
Self-citationKaewkangsadan, V., Verma, C., Eremin, J. M., Cowley, G., Ilyas, M., Satthaporn, S., & Eremin, O. (2017) · Journal of Immunology Research · doi:10.1155/2017/1049023 · Cited by 23
Nonomura, N., Takayama, H., Kawashima, A., Mukai, M., Nagahara, A., Nakai, Y., Nakayama, M., Tsujimura, A., Nishimura, K., Aozasa, K., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01563.x · Cited by 22
Transcription factor MafB is a marker of tumor-associated macrophages in both mouse and humans
Yadav, M. K., Inoue, Y., Nakane-Otani, A., Tsunakawa, Y., Jeon, H., Samir, O., Teramoto, A., Kulathunga, K., Kusakabe, M., Nakamura, M., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.125 · Cited by 22
Atılgan, A. O., Özdemir, B. H., Akçay, E. Y., Demirkan, Ö. A., Tekindal, M. A., & Özkardeş, H. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.10.011 · Cited by 21
Wei, Y., Wang, X., Shengjun, Y., Shaohui, Z., & Hongzhen, Z. (2018) · PubMed · Cited by 20
Larionova, I., Zavyalova, M. V., Riabov, V., Чердынцева, Н. В., & Kzhyshkowska, J. G. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.050 · Cited by 19
Self-citationMlynska, A., Povilaityte, E., Zemleckaite, I., Žilionytė, K., Strioga, M. M., Kraśko, J. A., Dobrovolskienė, N., Peng, M.-W., Intaitė, B., & Pašukonienė, V. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.12996 · Cited by 19
Gou, H., Zhou, L., Huang, J. M., & Chen, X.-C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9219 · Cited by 18
Takayama, H., Nonomura, N., Nishimura, K., Oka, D., Shiba, M., Nakai, Y., Nakayama, M., Tsujimura, A., Aozasa, K., & Okuyama, Ä. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08013.x · Cited by 16
Burmeister, K., Quagliata, L., Andreozzi, M., Eppenberger‐Castori, S., Matter, M. S., Perrina, V., Grobholz, R., Jochum, W., Horber, D., Moosmann, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175563 · Cited by 16
Chen, L., Li, Q., Zhou, X., Shi, Y., Yang, L., Xu, S., Chen, C., Cui, Y., Zhang, X., & Bian, X. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.025 · Cited by 14
Watanabe, H., Ohashi, K., Nishii, K., Seike, K., Makimoto, G., Hotta, K., Maeda, Y., & Kiura, K. (2019) · Internal Medicine · doi:10.2169/internalmedicine.2875-19 · Cited by 11
Gong, Z., Chen, J., Cheng, J., Sun, C., Jia, Q., Diao, X., & Zhu, B. (2018) · Clinical Lung Cancer · doi:10.1016/j.cllc.2018.03.011 · Cited by 10
Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer
Raphael, J., Gong, I. Y., Nofech‐Mozes, S., Bartlett, J., Nafisi, H., & Verma, S. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203493 · Cited by 7
Jafarov, S., & Link, K. (2018) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2018-17-4-88-98 · Cited by 6
Targeting the Tumor-Associated Macrophages for ‘Normalizing’ Cancer
Kzhyshkowska, J. G., Grigoryeva, E., & Larionova, I. (2020) · Human perspectives in health sciences and technology · doi:10.1007/978-3-030-32857-3_11 · Cited by 4
Self-citation
Cited by
The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
Wang, H., Yung, M. M. H., Ngan, H. Y. S., Chan, K. K. L., & Chan, D. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126560 · Cited by 254
The role of tumor-associated macrophages in tumor immune evasion
Huang, R., Kang, T., & Chen, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05777-4 · Cited by 230
Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells
Mierke, C. T. (2024) · Cells · doi:10.3390/cells13010096 · Cited by 146
Tumor-associated macrophage polarization in the inflammatory tumor microenvironment
Zou, Z., Lin, H., Li, M., & Lin, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1103149 · Cited by 100
Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis
Wei, Y.-T., Wang, X.-R., Yan, C., Huang, F., Zhang, Y., Liu, X., Wen, Z.-F., Sun, X.-T., Zhang, Y., Chen, Y.-Q., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4260 · Cited by 80
Metadata
- Authors
- Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-10-22
- Volume
- 10
- Pages
- 566511-566511
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3093826348
- Cited by
- 392
- References
- 276
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.